(Q35014833)

5 August 2017

title

Anti-proteinuric effect of sulodexide in immunoglobulin a nephropathy (English)

1 reference

5 August 2017

9

Curie Ahn

1 reference

5 August 2017

10

Kook-Hwan Oh

1 reference

5 August 2017

8

Hwajung Kim

1 reference

5 August 2017

3

Dong Wan Chae

1 reference

5 August 2017

4

Kwon Wook Joo

1 reference

5 August 2017

6

Suhnggwon Kim

1 reference

5 August 2017

1

Kitae Bang

1 reference

5 August 2017

2

Ho Jun Chin

1 reference

5 August 2017

Yon Su Kim

5

1 reference

5 August 2017

Kyung Don Ju

series ordinal

7

1 reference

5 August 2017

publication date

1 July 2011

1 reference

5 August 2017

published in

Yonsei Medical Journal

1 reference

5 August 2017

volume

52

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

588-594

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

5 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Glycosaminoglycan treatment in glomerulonephritis? An interesting option to investigate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

One year course of oral sulodexide in the management of diabetic nephropathy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Heparanase mediates cell adhesion independent of its enzymatic activity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

The effect of insulin and sulodexide (Vessel Due F) on diabetic foot syndrome: pilot study in elderly patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

The effect of glycosaminoglycan sulodexide on albuminuria in patients with diabetes mellitus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Predicting renal outcome in IgA nephropathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Heparin modulates proliferation and proteoglycan biosynthesis in murine mesangial cells: molecular clues for its activity in nephropathy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

The commonest glomerulonephritis in the world: IgA nephropathy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

A retrospective analysis of the natural history of primary IgA nephropathy worldwide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Sulodexide oral administration influences blood viscosity and fibrinolysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Presence of heparan sulfate in the glomerular basement membrane

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Immunoglobulin A nephropathy: a clinical perspective.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

A pilot study of the effect of the glycosaminoglycan sulodexide on microalbuminuria in type I diabetic patients.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104455

Distribution of de novo synthesized sulfated glycosaminoglycans in the glomerular basement membrane and mesangial matrix

25 October 2018

1 reference

12 December 2020

Antithrombotic activity of a glycosaminoglycan (sulodexide) in rats

1 reference

12 December 2020

[Effect of sulodexide on hemorheological parameters in a group of patients with peripheral arteriosclerotic vascular disease]

1 reference

12 December 2020

IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?

1 reference

12 December 2020

Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain

1 reference

12 December 2020

Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells

1 reference

12 December 2020

Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats

1 reference

12 December 2020

Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide

1 reference

12 December 2020

IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction

1 reference

12 December 2020

Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment

1 reference

12 December 2020

Glycosaminoglycans as a possible tool for micro- and macroalbuminuria in diabetic patients. A pilot study

1 reference

12 December 2020

Glycosaminoglycans Delay the Progression of Nephropathy in NIDDM

1 reference

12 December 2020

A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy

1 reference

12 December 2020

Effect of glycosaminoglycans on urinary albumin excretion in insulin-dependent diabetic patients with micro- or macroalbuminuria

1 reference

12 December 2020

Pharmacological actions of sulodexide

1 reference

12 December 2020

Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy

1 reference

12 December 2020

10.3349/YMJ.2011.52.4.588

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference